A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma

There are no reports of blood triglyceride (TG) levels increasing with the ABVD regimen. Herein, we present a case of Hodgkin's lymphoma that exhibited ABVD-induced blood TG increase. The patient was a 40-year-old Japanese man. Empiric therapy was initiated using the ABVD regimen for Hodgkin ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Yonezawa, Ryo, Shimamoto, Kazushi, Kabasawa, Nobuyuki, Sano, Mizuki, Tanaka, Shizuko, Matsui, Mitsuki, Harada, Hiroshi, Sunaga, Tomiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023944/
https://www.ncbi.nlm.nih.gov/pubmed/36941843
http://dx.doi.org/10.1016/j.lrr.2023.100365
_version_ 1784908997873106944
author Yonezawa, Ryo
Shimamoto, Kazushi
Kabasawa, Nobuyuki
Sano, Mizuki
Tanaka, Shizuko
Matsui, Mitsuki
Harada, Hiroshi
Sunaga, Tomiko
author_facet Yonezawa, Ryo
Shimamoto, Kazushi
Kabasawa, Nobuyuki
Sano, Mizuki
Tanaka, Shizuko
Matsui, Mitsuki
Harada, Hiroshi
Sunaga, Tomiko
author_sort Yonezawa, Ryo
collection PubMed
description There are no reports of blood triglyceride (TG) levels increasing with the ABVD regimen. Herein, we present a case of Hodgkin's lymphoma that exhibited ABVD-induced blood TG increase. The patient was a 40-year-old Japanese man. Empiric therapy was initiated using the ABVD regimen for Hodgkin lymphoma. On day 58, the fasting blood TG concentration increased to 1,451 mg/dL. Since no adverse events were noted, 0.2 mg/day of pemafibrate was administered, and the ABVD regimen was continued. Blood TG levels should be periodically monitored during ABVD administration for the patients who are at high risk of increased blood TG levels.
format Online
Article
Text
id pubmed-10023944
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100239442023-03-19 A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma Yonezawa, Ryo Shimamoto, Kazushi Kabasawa, Nobuyuki Sano, Mizuki Tanaka, Shizuko Matsui, Mitsuki Harada, Hiroshi Sunaga, Tomiko Leuk Res Rep Article There are no reports of blood triglyceride (TG) levels increasing with the ABVD regimen. Herein, we present a case of Hodgkin's lymphoma that exhibited ABVD-induced blood TG increase. The patient was a 40-year-old Japanese man. Empiric therapy was initiated using the ABVD regimen for Hodgkin lymphoma. On day 58, the fasting blood TG concentration increased to 1,451 mg/dL. Since no adverse events were noted, 0.2 mg/day of pemafibrate was administered, and the ABVD regimen was continued. Blood TG levels should be periodically monitored during ABVD administration for the patients who are at high risk of increased blood TG levels. Elsevier 2023-02-25 /pmc/articles/PMC10023944/ /pubmed/36941843 http://dx.doi.org/10.1016/j.lrr.2023.100365 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Yonezawa, Ryo
Shimamoto, Kazushi
Kabasawa, Nobuyuki
Sano, Mizuki
Tanaka, Shizuko
Matsui, Mitsuki
Harada, Hiroshi
Sunaga, Tomiko
A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
title A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
title_full A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
title_fullStr A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
title_full_unstemmed A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
title_short A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
title_sort case of blood triglyceride increased induced by abvd therapy for classical hodgkin lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023944/
https://www.ncbi.nlm.nih.gov/pubmed/36941843
http://dx.doi.org/10.1016/j.lrr.2023.100365
work_keys_str_mv AT yonezawaryo acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT shimamotokazushi acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT kabasawanobuyuki acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT sanomizuki acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT tanakashizuko acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT matsuimitsuki acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT haradahiroshi acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT sunagatomiko acaseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT yonezawaryo caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT shimamotokazushi caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT kabasawanobuyuki caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT sanomizuki caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT tanakashizuko caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT matsuimitsuki caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT haradahiroshi caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma
AT sunagatomiko caseofbloodtriglycerideincreasedinducedbyabvdtherapyforclassicalhodgkinlymphoma

Ejemplares similares